The two main types of noninvasive (in situ)
Ductal carcinoma in situ is the most common form of non-
Earlier this summer, the National Institutes of Health decided not to fund a breast cancer prevention trial to test Letrozole (Femara), an... Read more »
Once you’ve started breast cancer treatment–with a lumpectomy or mastectomy, or maybe you’re starting with chemotherapy–the... Read more »
The Halo system, a procedure whose results can be used to assess risk for breast cancer, was approved by the FDA in 2005. It was introduced... Read more »
A large part of the initial consultation with your oncologists (surgeon, radiation oncologist, and medical oncologist) is spent discussing... Read more »
There is a spectrum of changes in the breast tissue from normal tissue to breast cancer; it goes something like this: Normal ductal... Read more »
Q. I’ve just been diagnosed with LCIS. The doctor said it’s not really cancer; but if that’s the case, why is it called cancer? I’m... Read more »
Q. I’ve heard of women with DCIS and IDC, but I just found out I have ILC. What’s that?A. ILC–infiltrating lobular carcinoma–is similar to... Read more »
Source: ADAM Encyclopedia
Breast Cancer Screening GuidelinesMost guidelines recommend annual mammograms for women starting at age 40. The U.S. Preventive Services Task Force... Read more »
Source: Breastcancer.org
Unlike local treatments, which focus on the area (or areas) where the invasive lobular carcinoma (ILC) was found, systemic treatments involve the... Read more »
Source: Breastcancer.org
LCIS does not require treatment in the way you might normally think of cancer treatment, such as needing to have surgery, radiation therapy, and... Read more »